I appreciate you posting the info also. For whatever criticisms these boards deserve, this is why I keep checking back - very useful info is posted now and then. I think the silence is a combination of restraint and changes to the update protocol as a result of the deaths. The pace of enrollment and information can be frustrating but it has no effect on the outcome. Thanks for the tidbit!
interesting that there was no communication from ir to inform shareholders of why things went on hold. although it had been previously published there's no harm in making a reference to it, and it would have calmed some nerves. clearly, nviv is focused only on their fda relationship. that's fine with me. curious as to what the go-forward rate of enrollment will be. all in all, i feel a lot better.